Programmatic management of latent tuberculosis infection in the European Union

Public health guidance
Cite:
Citation Link

European Centre for Disease Prevention and Control. Programmatic management of latent tuberculosis infection in the European Union. Stockholm: ECDC; 2018. 

Copy citation to clipboard

Programmatic management of latent tuberculosis infection (LTBI) is a key component of any tuberculosis elimination strategy, as people with LTBI represent a large human reservoir for the disease. This document provides evidence-based guidance for the implementation of programmatic management of LTBI in the European Union and European Economic Area. The guidance covers four key areas in relation to programmatic management of LTBI: target risk groups; diagnosis; treatment; and programmatic issues of LTBI management.

Related updates on tuberculosis

Peer-Reviewed Publication

Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries

Aug 2019

Publication

Communicable disease threats report, 7-13 July 2019, week 28

Publication -

Peer-Reviewed Publication

Health crisis in Venezuela: Status of communicable diseases and implications for the European union and European economic area, may 2019

May 2019

Peer-Reviewed Publication

Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study

May 2019

Peer-Reviewed Publication

Whole-genome sequencing as tool for investigating international tuberculosis outbreaks: A systematic review

Apr 2019